Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PSA-1 and SELECT-PsA-2 trials assessed according to modified PsARC
主要な著者: | , , , , , , , , , , |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
Oxford University Press
2022
|